PHARMACY

Par distributes authorized generic of AstraZeneca hypertension drug

BY Alaric DeArment

WOODCLIFF LAKE, N.J. — Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

Par announced that it had entered a supply and distribution agreement through subsidiary Par Pharmaceutical to distribute an authorized generic version of Atacand HCT (i.e., candesartan cilexetil and hydrochlorothiazide) tablets.

An authorized generic is a branded drug marketed under its generic name at a discounted price, usually through a third-party company.

Par has started shipping the drug in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Atacand HCT has annual sales of aboutt $61 million, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

J&J subsidiary seeks new approval for psoriasis drug

BY Alaric DeArment

HORSHAM, Pa. — Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

J&J subsidiary Janssen Biotech submitted an application to the FDA for Stelara (ustekinumab) for adult patients with the disease, which affects more than 2 million people in the United States, according to the National Psoriasis Foundation. Another subsidiary is seeking approval for Stelara for the same usage in Europe.

"We are pleased to present applications to health authorities in the U.S. and Europe seeking approval of Stelara for the treatment of active psoriatic arthritis, a chronic, debilitating immune-mediated inflammatory diseases," Janssen Research and Development VP and head of immunology development Jerome Boscia said.

The drug is already approved for treating moderate to severe plaque psoriasis in adults.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

A.WAHID says:
Dec-07-2012 11:24 am

How can I recive stelara and what about the price and doses please

TRENDING STORIES

PHARMACY

Catamaran opens Indianapolis Center of Excellence

BY Alaric DeArment

LISLE, Ill. — Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

Catamaran announced the opening of the 13,000-square-foot center, which it said will support the services it will provide under the $60 million, six-year Medicaid contract with the Indiana state government, signed in October.

The center, one of 11 around the country, officially opened in a ribbon-cutting ceremony this week, attended by state officials and healthcare leaders, and will house pharmacists, pharmacy technicians and others.

"Catamaran’s Center of Excellence model is the cornerstone of our business strategy and allows us to organize our expertise and talent around a specific client to deliver industry-leading results," Catamaran segment president Dan Hardin said. "It’s a best-of-breed approach that has proven very effective in driving down the cost of healthcare while enhancing access to care and customer satisfaction."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES